CytomX Therapeutics, Inc.
NASDAQ:CTMX
0.6697 (USD) • At close March 10, 2025
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| 31.869 | -0.569 | -99.317 | -83.609 | -32.885 | -102.238 | -84.604 | -43.099 | -58.9 | -35.374 | -30.31 | -15.143 |
| Afschrijvingen & Amortisatie
| 0.146 | 2.175 | 2.443 | 2.706 | 2.573 | 2.605 | 1.884 | 1.645 | 1.733 | 1.206 | 0.783 | 0.655 |
| Uitgestelde Inkomstenbelasting
| 0 | 0 | 0 | 0.272 | -0.236 | -2.228 | 0 | -0.513 | 0.006 | 0.008 | 0.008 | 0.01 |
| Aandelen Gebaseerde Vergoedingen
| 7.668 | 8.558 | 13.125 | 13.167 | 14.786 | 19.1 | 16.878 | 11.287 | 10.095 | 3.986 | 0.553 | 0.343 |
| Verandering in Werkkapitaal
| -126.415 | -62.509 | -30.654 | -54.7 | 18.134 | -59.321 | -7.978 | 189.965 | 43.26 | -0.248 | 60.673 | 5.958 |
| Vorderingen
| 0.329 | 32.554 | -35.196 | 0.008 | -0.785 | 0.084 | 10.042 | -7.826 | -1.569 | 1.131 | -1.638 | -0.237 |
| Voorraden
| 0 | 0 | 0 | 11.64 | -11.115 | -11.29 | 19.914 | 10.319 | -0.253 | 1.807 | 0.188 | 0.329 |
| Crediteuren
| -0.297 | -1.426 | 0.068 | -0.139 | -0.857 | -0.374 | 0.261 | -2.441 | 1.765 | 2.944 | 0.66 | 0.366 |
| Overig Werkkapitaal
| -126.447 | -93.637 | 4.474 | -66.209 | 30.891 | -47.741 | -38.195 | 189.913 | 43.317 | -6.13 | 61.463 | 5.5 |
| Overige Niet-Contante Posten
| 0.501 | -3.69 | 3.615 | 3.133 | 2.887 | 1.602 | -1.701 | 11.088 | 1.774 | 3.007 | 0.095 | 0.169 |
| Kasstroom uit Operationele Activiteiten
| -86.231 | -56.035 | -110.788 | -119.031 | 5.259 | -140.48 | -75.521 | 170.373 | -2.032 | -27.415 | 31.802 | -8.008 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -0.31 | -0.84 | -1.74 | -1.609 | -2.309 | -3.497 | -3.788 | -1.559 | -2.176 | -1.594 | -1.663 | -0.732 |
| Netto Overnames
| 0 | 0 | 0 | -24.098 | 16.409 | -83.198 | -5.926 | 121.266 | 0.052 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| -155.49 | -424.834 | 0 | -99.898 | -199.108 | -174.992 | -204.601 | -218.707 | -121.517 | -250.901 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 255.5 | 275 | 100 | 123.996 | 182.699 | 258.19 | 214.315 | 99 | 169.5 | 122.75 | 0 | 0 |
| Overige Investeringsactiviteiten
| 0 | 0 | 100 | 24.098 | -16.409 | 83.198 | 5.926 | -121.266 | 0.052 | -0.817 | 0 | 0 |
| Kasstroom uit Investeringsactiviteiten
| 99.7 | -150.674 | 98.26 | 22.489 | -18.718 | 79.701 | 5.926 | -121.266 | 45.859 | -130.562 | -1.663 | -0.732 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.078 | -3.067 | -1.256 | 2.635 |
| Uitgifte van Gewone Aandelen
| 6.909 | 30.23 | 0.648 | 107.712 | 11.288 | 1.602 | 134.596 | 19.957 | 0.159 | 81.777 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.705 | 0 | 0 |
| Overige Financieringsactiviteiten
| 0.613 | 30.23 | 0.648 | 2.501 | 5.605 | 1.627 | 5.028 | 3.839 | 0.918 | 81.398 | 26.81 | 0.062 |
| Kasstroom uit Financieringsactiviteiten
| 7.522 | 30.23 | 0.648 | 110.213 | 16.893 | 1.627 | 139.624 | 23.796 | 0.996 | 153.403 | 25.554 | 2.697 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| 20.991 | -176.479 | -11.88 | 13.671 | 3.434 | -59.152 | 70.029 | 72.903 | 44.823 | -4.574 | 55.693 | -6.043 |
| Kaspositie aan het Einde van de Periode
| 39.079 | 18.088 | 194.567 | 206.447 | 192.776 | 189.342 | 248.494 | 177.548 | 104.645 | 59.822 | 64.396 | 8.703 |